Cantex and Headlamp Health are teaming up to accelerate the development of azeliragon for severe depression and fatigue in MS ...

The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...

MRI and disability scores better identify cognitive decline in stable RRMS patients than blood biomarkers, according to a new ...

Miniature brain models (organoids) help evaluate treatments for myelin damage in multiple sclerosis. These human-derived ...

This year's Bike MS event in Texas, the largest such U.S. fundraiser, brought in $9.2 million for research, advocacy, and ...

A new type of MRI scan may distinguish active from chronic MS lesions without the need for injected contrast dye.

Anti-CD20 therapies and S1P receptor modulators seem to be equally effective for most people with late-onset MS, a real-world ...

The first participant has been dosed in an investigator-led Phase 2 trial testing pegsebrenatide as a potential treatment for ...

Decode Health and Circular Genomics will use AI to identify patterns in circular RNA in blood that may help diagnose and ...

Researchers found the nerve damage biomarker NfL in menstrual fluid, meaning tampon-collected samples could help monitor ...

A pilot trial is enrolling patients to test whether vagus nerve stimulation can safely promote remyelination in adults with ...

Columnist Ben Hofmeister shares his insights about living with MS, and says people with the disease don't have to figure it out on their own.